EP2963116 - TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT 1 [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.09.2021 Database last updated on 13.07.2024 | |
Former | The patent has been granted Status updated on 09.10.2020 | ||
Former | Grant of patent is intended Status updated on 04.06.2020 | ||
Former | Examination is in progress Status updated on 26.01.2018 | ||
Former | Request for examination was made Status updated on 03.11.2016 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states CuRNA, Inc. 4400 Biscayne Boulevard Miami, FL 33137 / US | [2016/01] | Inventor(s) | 01 /
COLLARD, Joseph 1004 Brooks Lane Delray Beach, Florida 33483 / US | 02 /
KHORKOVA SHERMAN, Olga 18288 SE Heritage Drive Tequesta, Florida 33469 / US | 03 /
COITO, Carlos 4518 Corniche Circle 26 West Palm Beach, Florida 33417 / US | 04 /
DE LEON, Belinda 720 S. Sapodilla Avenue 305 West Palm Beach, Florida 33401 / US | [2020/46] |
Former [2016/01] | 01 /
COLLARD, Joseph 1004 Brooks Lane Delray Beach, FL Florida 33483 / US | ||
02 /
KHORKOVA SHERMAN, Olga 18288 SE Heritage Drive Tequesta, FL Florida 33469 / US | |||
03 /
COITO, Carlos 4518 Corniche Circle 26 West Palm Beach, FL Florida 33417 / US | |||
04 /
DE LEON, Belinda 720 S. Sapodilla Avenue 305 West Palm Beach, FL Florida 33401 / US | Representative(s) | Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [2020/46] |
Former [2016/01] | Evenson, Jane Harriet, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 15180416.8 | 03.03.2010 | [2016/01] | Priority number, date | US20090157255P | 04.03.2009 Original published format: US 157255 P | US20090259072P | 06.11.2009 Original published format: US 259072 P | WO2009US66445 | 02.12.2009 Original published format: PCT/US2009/066445 | [2016/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2963116 | Date: | 06.01.2016 | Language: | EN | [2016/01] | Type: | A3 Search report | No.: | EP2963116 | Date: | 23.03.2016 | Language: | EN | [2016/12] | Type: | B1 Patent specification | No.: | EP2963116 | Date: | 11.11.2020 | Language: | EN | [2020/46] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.02.2016 | Classification | IPC: | C12N15/63, C12N15/11, C07H19/00, C12Q1/68 | [2016/01] | CPC: |
C12N15/1137 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/00 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/04 (EP);
A61P19/10 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P25/32 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P31/14 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
C12Y305/01098 (EP,US);
C12N2310/11 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2016/01] | Title | German: | BEHANDLUNG VON SIRTUIN 1 (SIRT1)-BEDINGTEN ERKRANKUNGEN MITTELS HEMMUNG DES NATÜRLICHEN ANTISENSE-TRANSKRIPTS GEGEN SIRT 1 | [2016/01] | English: | TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT 1 | [2016/01] | French: | TRAITEMENT DE SIRTUINE 1 (SIRT1) ASSOCIÉE À DES MALADIES PAR INHIBITION DU TRANSCRIT ANTISENS NATUREL DE SIRT 1 | [2016/01] | Examination procedure | 10.08.2015 | Examination requested [2016/01] | 11.01.2017 | Amendment by applicant (claims and/or description) | 01.02.2018 | Despatch of a communication from the examining division (Time limit: M08) | 08.11.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 07.01.2019 | Reply to a communication from the examining division | 24.04.2019 | Despatch of a communication from the examining division (Time limit: M06) | 24.10.2019 | Reply to a communication from the examining division | 05.06.2020 | Communication of intention to grant the patent | 05.10.2020 | Fee for grant paid | 05.10.2020 | Fee for publishing/printing paid | 05.10.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP10749298.5 / EP2403946 | Opposition(s) | 12.08.2021 | No opposition filed within time limit [2021/42] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 07.01.2019 | Request for further processing filed | 07.01.2019 | Full payment received (date of receipt of payment) Request granted | 22.01.2019 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 11.01.2017 | Request for further processing filed | 11.01.2017 | Full payment received (date of receipt of payment) Request granted | 27.01.2017 | Decision despatched | Fees paid | Renewal fee | 10.08.2015 | Renewal fee patent year 03 | 10.08.2015 | Renewal fee patent year 04 | 10.08.2015 | Renewal fee patent year 05 | 10.08.2015 | Renewal fee patent year 06 | 31.03.2016 | Renewal fee patent year 07 | 27.03.2017 | Renewal fee patent year 08 | 27.03.2018 | Renewal fee patent year 09 | 27.03.2019 | Renewal fee patent year 10 | 27.03.2020 | Renewal fee patent year 11 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 03.03.2010 | AT | 11.11.2020 | CY | 11.11.2020 | CZ | 11.11.2020 | DK | 11.11.2020 | EE | 11.11.2020 | FI | 11.11.2020 | HR | 11.11.2020 | LT | 11.11.2020 | LV | 11.11.2020 | MC | 11.11.2020 | MK | 11.11.2020 | NL | 11.11.2020 | PL | 11.11.2020 | RO | 11.11.2020 | SE | 11.11.2020 | SI | 11.11.2020 | SK | 11.11.2020 | SM | 11.11.2020 | TR | 11.11.2020 | BG | 11.02.2021 | NO | 11.02.2021 | GR | 12.02.2021 | LU | 03.03.2021 | IS | 11.03.2021 | PT | 11.03.2021 | BE | 31.03.2021 | CH | 31.03.2021 | LI | 31.03.2021 | [2024/29] |
Former [2024/22] | HU | 03.03.2010 | |
AT | 11.11.2020 | ||
CY | 11.11.2020 | ||
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
MK | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
BE | 31.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2023/27] | HU | 03.03.2010 | |
AT | 11.11.2020 | ||
CY | 11.11.2020 | ||
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
BE | 31.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2023/24] | AT | 11.11.2020 | |
CY | 11.11.2020 | ||
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
BE | 31.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2022/34] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
BE | 31.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2022/23] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2022/10] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
PT | 11.03.2021 | ||
CH | 31.03.2021 | ||
LI | 31.03.2021 | ||
Former [2022/09] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
LU | 03.03.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/50] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SI | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/46] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
NL | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/45] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
MC | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/37] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
DK | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/36] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
EE | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/35] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
RO | 11.11.2020 | ||
SE | 11.11.2020 | ||
SK | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/34] | AT | 11.11.2020 | |
CZ | 11.11.2020 | ||
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
SE | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/33] | AT | 11.11.2020 | |
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LT | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
SE | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/32] | AT | 11.11.2020 | |
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
SE | 11.11.2020 | ||
SM | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/28] | AT | 11.11.2020 | |
FI | 11.11.2020 | ||
HR | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
SE | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/25] | AT | 11.11.2020 | |
FI | 11.11.2020 | ||
LV | 11.11.2020 | ||
PL | 11.11.2020 | ||
SE | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
IS | 11.03.2021 | ||
PT | 11.03.2021 | ||
Former [2021/24] | AT | 11.11.2020 | |
FI | 11.11.2020 | ||
LV | 11.11.2020 | ||
SE | 11.11.2020 | ||
BG | 11.02.2021 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
PT | 11.03.2021 | ||
Former [2021/23] | FI | 11.11.2020 | |
LV | 11.11.2020 | ||
SE | 11.11.2020 | ||
NO | 11.02.2021 | ||
GR | 12.02.2021 | ||
PT | 11.03.2021 | ||
Former [2021/22] | FI | 11.11.2020 | |
NO | 11.02.2021 | ||
PT | 11.03.2021 | ||
Former [2021/21] | FI | 11.11.2020 | |
PT | 11.03.2021 | ||
Former [2021/20] | FI | 11.11.2020 | Documents cited: | Search | [E]WO2010065662 (CURNA INC [US], et al) [E] 1-14 * claims 3,16-18,24 *; | [A] - KUEHBACHER ANGELIKA ET AL, "MicroRNA 92a Controls Vessel Growth And Functional Recovery After Ischemia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200810), Database accession no. PREV200900197869, XP002684082 [A] 1-14 * abstract * | [AP] - BONAUER ANGELIKA ET AL, "MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, (20090626), vol. 324, no. 5935, ISSN 0036-8075, pages 1710 - 1713, XP002575234 [AP] 1-14 * page 1711 * | [A] - SUN ET AL, "Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells", LUNG CANCER, ELSEVIER, AMSTERDAM, NL, (20070914), vol. 58, no. 1, doi:10.1016/J.LUNGCAN.2007.05.013, ISSN 0169-5002, pages 21 - 29, XP022242948 [A] 1-14 * page 23 * DOI: http://dx.doi.org/10.1016/j.lungcan.2007.05.013 | [A] - WAHLESTEDT ET AL, "Natural antisense and noncoding RNA transcripts as potential drug targets", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 11, no. 11-12, ISSN 1359-6446, (20060601), pages 503 - 508, (20060601), XP027889295 [A] 1-14 * page 505 * | [A] - MUNEKAZU YAMAKUCHI ET AL, "miR-34a repression of SIRT1 regulates apoptosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 105, no. 36, doi:10.1073/PNAS.0801613105, ISSN 0027-8424, (20080909), pages 13421 - 13426, (20080828), XP008149911 [A] 1-14 * page 13421 * DOI: http://dx.doi.org/10.1073/pnas.0801613105 | [A] - SMALHEISER N R ET AL, "Natural antisense transcripts are co-expressed with sense mRNAs in synaptoneurosomes of adult mouse forebrain", NEUROSCIENCE RESEARCH, ELSEVIER, SHANNON, IR, vol. 62, no. 4, doi:10.1016/J.NEURES.2008.08.010, ISSN 0168-0102, (20081201), pages 236 - 239, (20080904), XP025669354 [A] 1-14 * page 238 * DOI: http://dx.doi.org/10.1016/j.neures.2008.08.010 | [A] - THIMMAPPA S. ANEKONDA ET AL, "Neuronal protection by sirtuins in Alzheimer's disease", JOURNAL OF NEUROCHEMISTRY, (20060101), vol. 96, no. 2, doi:10.1111/j.1471-4159.2005.03492.x, ISSN 0022-3042, pages 305 - 313, XP055039113 [A] 1-14 * page 307 * DOI: http://dx.doi.org/10.1111/j.1471-4159.2005.03492.x | [A] - "Mus musculus 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030437B01 product:synembryn, full insert sequence.", ENA, (20080923), Database accession no. AK031466, URL: EBI, XP002745421 [A] 1-14 * sequence . * | [I] - "xj35b03.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2659181 3', mRNA sequence.", ENA, (20000304), Database accession no. AW169958, URL: EBI, XP002745422 [I] 1-14 * sequence . * | [AP] - APARNA PURUSHOTHAM ET AL, "Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation", CELL METABOLISM, (20090408), vol. 9, no. 4, doi:10.1016/j.cmet.2009.02.006, ISSN 1550-4131, pages 327 - 338, XP055039151 [AP] 1-14 * page 328 * DOI: http://dx.doi.org/10.1016/j.cmet.2009.02.006 | Examination | - "Mus musculus adult retina cDNA, RIKEN full-length enriched library, clone:A930026H04 product:hypothetical protein, full insert sequence.", EMBL, (20080923), Database accession no. AK044604, URL: EBI | - L R Saunders ET AL, "Sirtuins: critical regulators at the crossroads between cancer and aging", ONCOGENE, (20070801), vol. 26, no. 37, doi:10.1038/sj.onc.1210616, ISSN 0950-9232, pages 5489 - 5504, XP055439842 DOI: http://dx.doi.org/10.1038/sj.onc.1210616 | by applicant | US5432272 | US7544497 | US5013830 | US5149797 | US5220007 | US5256775 | US5366878 | US5403711 | US5491133 | US5565350 | US5623065 | US5652355 | US5652356 | US5700922 | US5034506 | US5138045 | US5218105 | US5459255 | US3687808 | US4469863 | US4476301 | US5023243 | US5177196 | US5188897 | US5264423 | US5276019 | US5278302 | US5286717 | US5321131 | US5399676 | US5405939 | US5453496 | US5455233 | US5466677 | US5476925 | US5519126 | US5536821 | US5541306 | US5550111 | US5563253 | US5571799 | US5587361 | US5625050 | US5166315 | US5185444 | US5214134 | US5216141 | US5235033 | US5264562 | US5264564 | US5405938 | US5434257 | US5470967 | US5489677 | US5541307 | US5561225 | US5596086 | US5602240 | US5610289 | US5608046 | US5618704 | US5623070 | US5663312 | US5633360 | US5677437 | US5677439 | US5539082 | US5714331 | US5719262 | US4981957 | US5118800 | US5319080 | US5359044 | US5393878 | US5446137 | US5466786 | US5514785 | US5519134 | US5567811 | US5576427 | US5591722 | US5597909 | US5610300 | US5627053 | US5639873 | US5646265 | US5658873 | US5670633 | US5700920 | US4845205 | US5130302 | US5134066 | US5175273 | US5367066 | US5457187 | US5484908 | US5502177 | US5525711 | US5552540 | US5587469 | US5596091 | US5614617 | US5750692 | US5681941 | US4828979 | US4948882 | US5525465 | US5541313 | US5545730 | US5552538 | US5578717 | US5580731 | US5591584 | US5109124 | US5118802 | US5414077 | US5486603 | US5512439 | US5578718 | US4587044 | US4605735 | US4667025 | US4762779 | US4789737 | US4824941 | US4835263 | US4876335 | US4904582 | US4958013 | US5082830 | US5112963 | US5214136 | US5245022 | US5254469 | US5258506 | US5262536 | US5272250 | US5292873 | US5317098 | US5371241 | US5391723 | US5416203 | US5451463 | US5510475 | US5512667 | US5565552 | US5567810 | US5574142 | US5585481 | US5587371 | US5595726 | US5597696 | US5599923 | US5599928 | US5688941 | US6287860 | US5108921 | US5354844 | US5416016 | US5459127 | US5521291 | US5543165 | US5547932 | US5583020 | US5591721 | US4426330 | US4534899 | US5013556 | US5213804 | US5227170 | US5264221 | US5356633 | US5395619 | US5417978 | US5462854 | US5469854 | US5512295 | US5527528 | US5534259 | US5543152 | US5556948 | US5580575 | US5595756 | US2007117772 | US6632427 | US6756523 | US4866042 | US6294520 | US6936589 | US7563884 | - EGUCHI ET AL., ANN. REV. BIOCHEM., (1991), vol. 60, pages 631 - 652 | - CAPLEN, N. J. ET AL., PROC. NATL. ACAD. SCI. USA, (2001), vol. 98, pages 9742 - 9747 | - BERNSTEIN, E. ET AL., NATURE, (2001), vol. 409, pages 363 - 366 | - BOUTLA, A. ET AL., CURR. BIOL., (2001), vol. 11, pages 1776 - 1780 | - CECH, J. AMERICAN. MED. ASSOC., (1988), vol. 260, pages 3030 - 3035 | - SULLENGER ET AL., CELL, (1990), vol. 63, pages 601 - 608 | - FREIER; ALTMANN, NUCL. ACID. RES., (1997), vol. 25, no. 22, pages 4429 - 4443 | - TOULME, J.J., NATURE BIOTECHNOLOGY, (2001), vol. 19, pages 17 - 18 | - MANOHARAN M., BIOCHEMICA ET BIOPHYSICA ACTA, (1999), vol. 1489, pages 117 - 139 | - FREIER S. M., NUCLEIC ACID RESEARCH, (1997), vol. 25, pages 4429 - 4443 | - UHLMAN, E., DRUG DISCOVERY & DEVELOPMENT, (2000), vol. 3, pages 203 - 213 | - HERDEWIN P., ANTISENSE & NUCLEIC ACID DRUG DEV., (2000), vol. 10, pages 297 - 310 | - N.K CHRISTIENSEN. ET AL., J. AM. CHEM. SOC., (1998), vol. 120, pages 5458 - 5463 | - PRAKASH TP; BHAT B., CURR TOP MED CHEM., (2007), vol. 7, no. 7, pages 641 - 9 | - CHO EJ, ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, (2009), vol. 2, pages 241 - 264 | - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410 | - ZHANG; MADDEN, GENOME RES., (1997), vol. 7, pages 649 - 656 | - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489 | - BATEMAN A ET AL., "The Pfam Protein Families Database", NUCLEIC ACIDS RESEARCH, (2002), vol. 30, no. 1, pages 276 - 280 | - SONHAMMER ET AL., PROTEINS, (1997), vol. 28, no. 3, pages 405 - 420 | - GRIBSKOV ET AL., METH. ENZYMOL., (1990), vol. 183, pages 146 - 159 | - GRIBSKOV ET AL., PROC. NATL. ACAD. SCI. USA, (1987), vol. 84, pages 4355 - 4358 | - KROGH, J. MOL. BIOL., (1994), vol. 235, pages 1501 - 1531 | - STULTZ ET AL., PROTEIN SCI., (1993), vol. 2, pages 305 - 314 | - HAN SH, J CLIN NEUROL., (2009), vol. 5, no. 3, pages 120 - 5 | - MICHAN S ET AL., BIOCHEM J., (2007), vol. 404, no. 1, pages 1 - 13 | - FISCHER LR ET AL., EXP NEURO/, (2004), vol. 185, pages 232 - 240 | - STOKIN GB ET AL., SCIENCE, (2005), vol. 307, pages 1282 - 1288 | - YAMAMOTO H ET AL., MOL ENDOCRINOL, (2007), vol. 21, no. 8, pages 1745 - 1755 | - CHENG, J. ET AL., SCIENCE, (2005), vol. 308, no. 5725, pages 1149 - 1154 | - KAPRANOV, P. ET AL., GENOME RES, (2005), vol. 15, no. 7, pages 987 - 997 | - FIRE ET AL., NATURE, (1998), vol. 391, pages 806 - 811 | - TIMMONS; FIRE, NATURE, (1998), vol. 395, page 854 | - TIMMONS ET AL., GENE, (2001), vol. 263, pages 103 - 112 | - TABARA ET AL., SCIENCE, (1998), vol. 282, pages 430 - 431 | - MONTGOMERY ET AL., PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 15502 - 15507 | - TUSCHL ET AL., GENES DEV., (1999), vol. 13, pages 3191 - 3197 | - ELBASHIR ET AL., NATURE, (2001), vol. 411, pages 494 - 498 | - ELBASHIR ET AL., GENES DEV., (2001), vol. 15, pages 188 - 200 | - TIJSTERMAN ET AL., SCIENCE, (2002), vol. 295, pages 694 - 697 | - ZAUG ET AL., NATURE, (1986), vol. 324, page 429 | - CECH, JAMA, (1988), vol. 260, page 3030 | - JEFFERIES ET AL., NUCLEIC ACIDS RESEARCH, (1989), vol. 17, page 1371 | - USMAN; MCSWIGGEN, ANN. REP. MED. CHEM., (1995), vol. 30, pages 285 - 294 | - CHRISTOFFERSEN; MARR, J. MED. CHEM., (1995), vol. 38, pages 2023 - 2037 | - ORGEL, PROC. R. SOC. LONDON, (1979), vol. 205, page 435 | - JOYCE, GENE, (1989), vol. 82, pages 83 - 87 | - BEAUDRY ET AL., SCIENCE, (1992), vol. 257, pages 635 - 641 | - JOYCE, SCIENTIFIC AMERICAN, (1992), vol. 267, pages 90 - 97 | - BREAKER ET AL., TIBTECH, (1994), vol. 12, page 268 | - BARTEL ET AL., SCIENCE, (1993), vol. 261, pages 1411 - 1418 | - SZOSTAK, TIBS, (1993), vol. 17, pages 89 - 93 | - KUMAR ET AL., FASEB J., (1995), vol. 9, page 1183 | - BREAKER, CURR. OP. BIOTECH., (1996), vol. 7, page 442 | - UHLENBECK, O. C., NATURE, (1987), vol. 328, pages 596 - 600 | - HASELOFF; GERLACH, NATURE, (1988), vol. 334, page 585 | - WALBOT; BRUENING, NATURE, (1988), vol. 334, page 196 | - KOIZUMI, M. ET AL., FEBS LETT., (1988), vol. 228, pages 228 - 230 | - HAMMOND ET AL., NAT. REV. GENET., (1991), vol. 2, pages 110 - 119 | - MATZKE ET AL., CURR. OPIN. GENET. DEV., (2001), vol. 11, pages 221 - 227 | - SHARP, GENES DEV., (2001), vol. 15, pages 485 - 490 | - FU ET AL., "Hormonal Control of Androgen Receptor Function through SIRTl", MOLECULAR AND CELLULAR BIOLOGY, (2006), vol. 26, no. 21, pages 8122 - 8135 | - Encyclopedia of Pharmaceutical Technology, NEW YORK: MARCEL DEKKER, (1992), vol. 9 | - DE MESMAEKER ET AL., ACC. CHEM. RES., (1995), vol. 28, pages 366 - 374 | - NIELSEN ET AL., SCIENCE, (1991), vol. 254, page 1497 | - MARTIN ET AL., HELV. CHIM. ACTA, (1995), vol. 78, page 486 | - KORNBERG, A., DNA Replication, W. H. FREEMAN & CO., (1980), pages 75 - 77 | - GEBEYEHU, G. ET AL., NUCL. ACIDS RES., (1987), vol. 15, page 4513 | - Antisense Research and Applications, CRC PRESS, (1993), pages 276 - 278 | - LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 6553 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1994), vol. 4, page 1053 | - MANOHARAN ET AL., ANN. N.Y. ACAD. SCI., (1992), vol. 660, page 306 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1993), vol. 3, page 2765 | - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, page 533 | - SAISON-BEHMOARAS ET AL., EMBO J., (1991), vol. 10, page 111 | - KABANOV ET AL., FEBS LETT., (1990), vol. 259, page 327 | - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, page 49 | - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, page 3651 | - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, page 3777 | - MANOHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, page 969 | - UHLMAN ET AL., CURRENT OPINIONS IN DRUG DISCOVERY & DEVELOPMENT, (2000), vol. 3, no. 2 | - NIELSEN ET AL., SCIENCE, (1991), vol. 254, pages 1497 - 1500 | - MARTIN ET AL., HELV. CHIM. ACTA, (1995), vol. 78, pages 486 - 504 | - The Concise Encyclopedia of Polymer Science And Engineering, JOHN WILEY & SONS, (1990), pages 858 - 859 | - ENGLISCH ET AL., ANGEWANDLE CHEMIE, INTERNATIONAL EDITION, (1991), vol. 30, page 613 | - SANGHVI, Y.S.; CROOKE, S.T.; LEBLEU, B. EA., Antisense Research and Applications, CRC PRESS, (1993), pages 289 - 302 | - LETSINGER ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 6553 - 6556 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1994), vol. 4, pages 1053 - 1060 | - MANOHARAN ET AL., ANN. N. Y ACAD. SCI., (1992), vol. 660, pages 306 - 309 | - MANOHARAN ET AL., BIOORG. MED. CHEM. LET., (1993), vol. 3, pages 2765 - 2770 | - OBERHAUSER ET AL., NUCL. ACIDS RES., (1992), vol. 20, pages 533 - 538 | - KABANOV ET AL., FEBS LETT., (1990), vol. 259, pages 327 - 330 | - SVINARCHUK ET AL., BIOCHIMIE, (1993), vol. 75, pages 49 - 54 | - MANOHARAN ET AL., TETRAHEDRON LETT., (1995), vol. 36, pages 3651 - 3654 | - SHEA ET AL., NUCL. ACIDS RES., (1990), vol. 18, pages 3777 - 3783 | - MANCHARAN ET AL., NUCLEOSIDES & NUCLEOTIDES, (1995), vol. 14, pages 969 - 973 | - MISHRA ET AL., BIOCHIM. BIOPHYS. ACTA, (1995), vol. 1264, pages 229 - 237 | - CROOKE ET AL., J. PHARMACOL. EXP. THER., (1996), vol. 277, pages 923 - 937 | - BRAZMA; VILO, FEBS LETT., (2000), vol. 480, pages 17 - 24 | - CELIS ET AL., FEBS LETT., (2000), vol. 480, pages 2 - 16 | - MADDEN ET AL., DRUG DISCOV. TODAY, (2000), vol. 5, pages 415 - 425 | - PRASHAR; WEISSMAN, METHODS ENZYMOL., (1999), vol. 303, pages 258 - 72 | - SUTCLIFFE ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2000), vol. 97, pages 1976 - 81 | - JUNGBLUT ET AL., ELECTROPHORESIS, (1999), vol. 20, pages 2100 - 10 | - LARSSON ET AL., J. BIOTECHNOL., (2000), vol. 80, pages 143 - 57 | - FUCHS ET AL., ANAL. BIOCHEM., (2000), vol. 286, pages 91 - 98 | - LARSON ET AL., CYTOMETRY, (2000), vol. 41, pages 203 - 208 | - JURECIC; BELMONT, CURR. OPIN. MICROBIOL., (2000), vol. 3, pages 316 - 21 | - CARULLI ET AL., J. CELL BIOCHEM. SUPPL., (1998), vol. 31, pages 286 - 96 | - GOING; GUSTERSON, EUR. J. CANCER, (1999), vol. 35, pages 1895 - 904 | - TO, COMB., CHEM. HIGH THROUGHPUT SCREEN, (2000), vol. 3, pages 235 - 41 | - GELLER, A.I. ET AL., J. NEUROCHEM, (1995), vol. 64, page 487 | - GELLER, A.I. ET AL., PROC NATL. ACAD. SCI.: U.S.A., (1993), vol. 90, page 7603 | - GELLER, A.I. ET AL., PROC NATL. ACAD. SCI USA, (1990), vol. 87, page 1149 | - LEGAL LASALLE ET AL., SCIENCE, (1993), vol. 259, page 988 | - DAVIDSON ET AL., NAT. GENET., (1993), vol. 3, page 219 | - YANG ET AL., J. VIROL., (1995), vol. 69, page 2004 | - KAPLITT, M.G. ET AL., NAT. GENET., (1994), vol. 8, page 148 | - PURUSHOTHAM A. ET AL., CELL METABOLISM, (2009), vol. 9, pages 327 - 338 | WO1992US09196 |